 Connection
Qiang Fu to fms-Like Tyrosine Kinase 3
This is a "connection" page, showing publications Qiang Fu has written about fms-Like Tyrosine Kinase 3.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.024 |
|
|
|
-
Fu Q, Wang Y, Liu H, Gao H, Sun W, Jiang Q, Jiang H, Liu K, Huang X, Tang F. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3mut acute myeloid leukemia. Leuk Res. 2024 Oct; 145:107564.
Score: 0.905
-
Yu S, Yang S, Hu L, Duan W, Zhao T, Ruan G, Qin Y, Wang Y, Lai Y, Shi H, Tang F, Sun Y, Jia J, Wang J, Fu Q, Jiang H, Xu L, Wang Y, Zhang X, Huang X, Jiang Q. Prognostic covariates associated with outcomes in patients with NPM1-mutated acute myeloid leukemia. Oncologist. 2025 Sep 01; 30(9).
Score: 0.061
-
Yu S, Yang S, Hu L, Duan W, Zhao T, Qin Y, Wang Y, Lai Y, Shi H, Tang F, Sun Y, Jia J, Wang J, Lu S, Fu Q, Jiang H, Xu L, Wang Y, Zhang X, Huang X, Jiang Q. Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia. Ann Hematol. 2025 Feb; 104(2):997-1006.
Score: 0.058
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|